Have a feature idea you'd love to see implemented?
Let us know!
STTK Shattuck Labs Inc
Price (delayed)
$1.215
Market cap
$58M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.53
Enterprise value
$16.92M
Shattuck Labs, Inc. operates as a clinical-stage biotechnology company . The Company focuses on developing a novel class of biologic medicines for the treatment of cancer and autoimmune diseases. Shattuck
Highlights
Shattuck Labs's gross profit has surged by 56% QoQ
STTK's revenue has surged by 56% since the previous quarter
The company's equity fell by 14% YoY and by 13% QoQ
Key stats
What are the main financial stats of STTK
Market
Valuations
Earnings
Shares outstanding
47.74M
Market cap
$58M
Enterprise value
$16.92M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.6
Price to sales (P/S)
9.6
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.63
Revenue
$6.44M
Gross profit
$6.44M
Net income
-$74.42M
EBIT
-$74.42M
EBITDA
-$70.14M
Free cash flow
-$62.64M
Per share
Balance sheet
Liquidity
EPS
-$1.53
EPS diluted
-$1.53
Free cash flow per share
-$1.23
Book value per share
$2.02
Revenue per share
$0.13
TBVPS
$2.2
Total assets
$111.72M
Total liabilities
$15.14M
Debt
$2.74M
Equity
$96.58M
Working capital
$86.34M
Debt to equity
0.03
Current ratio
7.96
Quick ratio
7.26
Net debt/EBITDA
0.59
Margins
Efficiency
Dividend
EBITDA margin
-1,089.9%
Gross margin
100%
Net margin
-1,156.5%
Operating margin
-1,241.3%
Return on assets
-54.5%
Return on equity
-61.9%
Return on invested capital
-149.4%
Return on capital employed
-74.9%
Return on sales
-1,156.5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
STTK stock price
How has the Shattuck Labs stock price performed over time
Intraday
0.41%
1 week
9.46%
1 month
11.47%
1 year
-83.93%
YTD
0.41%
QTD
0.41%
Financial performance
How have Shattuck Labs's revenue and profit performed over time
Revenue
$6.44M
Gross profit
$6.44M
Operating income
-$79.88M
Net income
-$74.42M
Gross margin
100%
Net margin
-1,156.5%
The net margin has surged by 84% year-on-year and by 44% since the previous quarter
STTK's operating margin has surged by 83% year-on-year and by 43% since the previous quarter
Shattuck Labs's gross profit has surged by 56% QoQ
STTK's revenue has surged by 56% since the previous quarter
Growth
What is Shattuck Labs's growth rate over time
Valuation
What is Shattuck Labs stock price valuation
P/E
N/A
P/B
0.6
P/S
9.6
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.63
Shattuck Labs's EPS has increased by 32% YoY and by 17% from the previous quarter
The stock's price to book (P/B) is 73% less than its last 4 quarters average of 2.2 and 71% less than its 5-year quarterly average of 2.1
The company's equity fell by 14% YoY and by 13% QoQ
STTK's price to sales (P/S) is 94% lower than its 5-year quarterly average of 158.4 and 91% lower than its last 4 quarters average of 106.2
STTK's revenue has surged by 56% since the previous quarter
Efficiency
How efficient is Shattuck Labs business performance
Shattuck Labs's ROS has soared by 84% YoY and by 44% from the previous quarter
The ROIC has shrunk by 53% YoY but it is up by 3.5% QoQ
STTK's return on assets is up by 10% since the previous quarter and by 4% year-on-year
The ROE has grown by 10% since the previous quarter and by 4.8% year-on-year
Dividends
What is STTK's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for STTK.
Financial health
How did Shattuck Labs financials performed over time
STTK's total liabilities is down by 16% since the previous quarter and by 14% year-on-year
STTK's total assets is down by 14% year-on-year and by 13% since the previous quarter
The debt is 97% smaller than the equity
The debt has declined by 24% year-on-year and by 8% since the previous quarter
The company's equity fell by 14% YoY and by 13% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.